Imunon (FRA:CBO0) Cyclically Adjusted FCF per Share: €-273.78 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CBO0 Imunon Inc FRA:CBO0
26 GF Score
Price €1.54
! 3 Warning Signs
View Full Analysis

What is Imunon Cyclically Adjusted FCF per Share?

Imunon FRA:CBO0 -2.53% 26 Cyclically Adjusted FCF per Share is €-273.78 as of Mar. 2026. GuruFocus rates FRA:CBO0 with a GF Score™ of 26/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Imunon's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.685. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-273.78 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 32.00% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 34.10% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 24.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Imunon was 38.10% per year. The lowest was -7.10% per year. And the median was 10.90% per year.

As of today (2026-07-18), Imunon's current stock price is €1.54. Imunon's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-273.78. Imunon's Cyclically Adjusted Price-to-FCF of today is .


Imunon  (FRA:CBO0) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Imunon Cyclically Adjusted FCF per Share Related Terms


Imunon Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Imunon's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imunon Cyclically Adjusted FCF per Share Chart

Imunon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,884.97 -1,233.66 -985.60 -594.58 -311.77

Imunon Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -620.41 -436.51 -395.03 -311.77 -273.78

FRA:CBO0 vs KAPA, HCWB, CURX: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Imunon's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imunon Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Imunon's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Imunon's Cyclically Adjusted Price-to-FCF falls into.


FRA:CBO0
26GF Score
Imunon Inc FRA:CBO0
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imunon Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Imunon's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.685/330.2130*330.2130
=-0.685

Current CPI (Mar. 2026) = 330.2130.

Imunon Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -422.444 241.018 -578.780
201609 -421.200 241.428 -576.096
201612 -443.400 241.432 -606.450
201703 -327.444 243.801 -443.502
201706 -109.824 244.955 -148.049
201709 -104.512 246.819 -139.824
201712 -40.420 246.524 -54.142
201803 -42.211 249.554 -55.854
201806 -40.022 251.989 -52.446
201809 -40.209 252.439 -52.597
201812 57.609 251.233 75.720
201903 -51.296 254.202 -66.634
201906 -39.981 256.143 -51.542
201909 -37.252 256.759 -47.909
201912 -38.386 256.974 -49.326
202003 -34.159 258.115 -43.700
202006 -17.137 257.797 -21.951
202009 -19.351 260.280 -24.550
202012 -15.835 260.474 -20.075
202103 -30.955 264.877 -38.591
202106 -5.130 271.696 -6.235
202109 -7.394 274.310 -8.901
202112 -10.217 278.802 -12.101
202203 -16.502 287.504 -18.953
202206 -9.871 296.311 -11.000
202209 -8.721 296.808 -9.703
202212 -7.151 296.797 -7.956
202303 -5.942 301.836 -6.501
202306 -9.161 305.109 -9.915
202309 -6.142 307.789 -6.589
202312 -4.798 306.746 -5.165
202403 -7.510 312.332 -7.940
202406 -5.813 314.175 -6.110
202409 -2.835 315.301 -2.969
202412 -3.248 315.605 -3.398
202503 -2.208 319.799 -2.280
202506 -1.753 322.561 -1.795
202509 -1.285 324.800 -1.306
202512 -1.068 324.054 -1.088
202603 -0.685 330.213 -0.685

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-273.78 mean?
Imunon (FRA:CBO0) has a Cyclically Adjusted FCF per Share of €-273.78 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Imunon and its competitors.
Is Imunon's Cyclically Adjusted FCF per Share too high?
Imunon's current Cyclically Adjusted FCF per Share is €-273.78. Overall, Imunon has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Imunon's Cyclically Adjusted FCF per Share compare to KAPA and HCWB?
Imunon's Cyclically Adjusted FCF per Share of €-273.78 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Imunon and its competitors. Imunon's current Cyclically Adjusted FCF per Share is €-273.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imunon stock overvalued right now?
Imunon (FRA:CBO0) has a current Cyclically Adjusted FCF per Share of €-273.78. The current Cyclically Adjusted FCF per Share is €-273.78. Imunon's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Imunon (FRA:CBO0), the current Cyclically Adjusted FCF per Share is €-273.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imunon Business Description

Other Exchanges IMNN:USACBO0:Germany
Address 997 Lenox Drive, Suite 100, Lawrenceville, NJ, USA, 08648
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.
26GF Score

Get the complete analysis for FRA:CBO0

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.54
Price